Immunohistochemistry to active
caspase-3, recently recommended for apoptosis detection, is inappropriate to detect apoptosis involving
caspase-7. Cleavage of
poly-ADP-ribose polymerase 1 (PARP-1), a major substrate of both
caspases, is a valuable marker of apoptosis. Apoptosis evaluation induced in vitro either by
paclitaxel or by photodynamic treatment (
PDT) with
Foscan in HT29 or KB monolayer cells and HT29 spheroids yielded a close percentage of labeled cells whatever the antibody used, whereas in control specimens, cleaved PARP (c-PARP) immunostaining failed to detect apoptosis as efficiently as active
caspase-3 or -7 immunostaining. Studies in MDA-MB231 monolayer cells and HT29 xenografts either subjected or not subjected to
Foscan-
PDT resulted in a significant higher number of active caspase-3-labeled cells, although immunofluorescence analysis showed c-PARP and active
caspase-3 perfectly colocalized in
tumors. A restricted expression of c-PARP was obvious in the greater part of
caspase-3 expressing cells from control
tumor, whereas photosensitized
tumors showed a higher number of cells expressing large fluorescent spots from both active
caspase-3 and c-PARP. These results support the assumption that c-PARP expression was dependent on treatment-induced apoptosis. The absence of
caspase-7 activation in some caspase-3-expressing cells undergoing
Foscan-
PDT shows the relevance of using
antibodies that can discriminate
caspase-dependent apoptotic pathways.